188 related articles for article (PubMed ID: 17361)
1. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
Hornykiewicz O
Annu Rev Pharmacol Toxicol; 1977; 17():545-59. PubMed ID: 17361
[No Abstract] [Full Text] [Related]
2. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
Hornykiewicz O
Neuroscience; 1978; 3(9):773-83. PubMed ID: 30919
[No Abstract] [Full Text] [Related]
3. Parkinsonism induced by dopaminergic antagonists.
Hornykiewicz O
Adv Neurol; 1975; 9():155-64. PubMed ID: 1096571
[No Abstract] [Full Text] [Related]
4. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction.
Randrup A
Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170
[No Abstract] [Full Text] [Related]
5. [Possible participation of limbic structures of the forebrain in the mechanism of the antipsychotic effect of neuroleptic preparations in schizophrenia (review)].
Aksent'ev SB; Mokhovikov AN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(8):1254-60. PubMed ID: 6137921
[No Abstract] [Full Text] [Related]
6. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].
Płaźnik A; Kostowski W
Psychiatr Pol; 1984; 18(1):39-47. PubMed ID: 6146150
[No Abstract] [Full Text] [Related]
7. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
Arushanian EB
Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
[No Abstract] [Full Text] [Related]
8. Pharmacotherapy of schizophrenia.
Ban TA
Curr Psychiatr Ther; 1976; 16():163-75. PubMed ID: 991627
[No Abstract] [Full Text] [Related]
9. Clinical evidence for multiple dopamine receptors in man.
Meltzer HY
Commun Psychopharmacol; 1979; 3(6):457-70. PubMed ID: 44694
[No Abstract] [Full Text] [Related]
10. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
Lideman RR; Zlobina GP; Mukhin AG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
[No Abstract] [Full Text] [Related]
11. [Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation].
Costentin J
Encephale; 1979; 5(2):121-49. PubMed ID: 38958
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptics as a guideline to biological research in psychotic disorders.
van Praag HM
Compr Psychiatry; 1975; 16(1):7-22. PubMed ID: 1089049
[No Abstract] [Full Text] [Related]
13. Dopamine and schizophrenia.
Crow TJ; Johnstone EC; Longden A; Owen F
Adv Biochem Psychopharmacol; 1978; 19():301-9. PubMed ID: 29450
[No Abstract] [Full Text] [Related]
14. [Effect of psychotropic drugs on the central dopamine metabolism (example: neuroleptics)].
Havemann U
Arzneimittelforschung; 1981; Suppl 27():18-22. PubMed ID: 6118158
[No Abstract] [Full Text] [Related]
15. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs.
Baldessarini RJ; Tarsy D
Annu Rev Neurosci; 1980; 3():23-41. PubMed ID: 6106450
[No Abstract] [Full Text] [Related]
16. Topographical distribution and characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the rat frontal cerebral cortex, striatum, and substantia nigra.
Bockaert J; Premont J; Glowinski J; Tassin JP; Thierry AM
Adv Biochem Psychopharmacol; 1977; 16():29-37. PubMed ID: 196489
[No Abstract] [Full Text] [Related]
17. Dopamine receptor mechanisms: behavioral and electrophysiological studies.
Ungerstedt U; Ljungberg T; Schultz W
Adv Biochem Psychopharmacol; 1978; 19():311-21. PubMed ID: 29451
[No Abstract] [Full Text] [Related]
18. Preferential effect of noncataleptogenic neuroleptics on mesolimbic dopaminergic function.
Bartholini G
Adv Biochem Psychopharmacol; 1977; 16():607-11. PubMed ID: 18902
[No Abstract] [Full Text] [Related]
19. [Action of etmozin and ethacizin on dopaminergic adenylate cyclase of the striate system of the brain].
Baldenkov GN; Ratner EI; Rozenshtraukh LV; Tkachuk VA
Biull Eksp Biol Med; 1984 Oct; 98(10):448-50. PubMed ID: 6149776
[TBL] [Abstract][Full Text] [Related]
20. The dopamine hypothesis of schizophrenia revisited.
van Kammen DP
Psychoneuroendocrinology; 1979 Jan; 4(1):37-46. PubMed ID: 39306
[No Abstract] [Full Text] [Related]
[Next] [New Search]